Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Raw Materials (2020 - 2021)

Historic Raw Materials for UroGen Pharma (URGN) over the last 2 years, with Q1 2021 value amounting to $2.4 million.

  • UroGen Pharma's Raw Materials changed N/A to $2.4 million in Q1 2021 from the same period last year, while for Mar 2021 it was $2.4 million, marking a year-over-year change of. This contributed to the annual value of $1.1 million for FY2020, which is N/A changed from last year.
  • As of Q1 2021, UroGen Pharma's Raw Materials stood at $2.4 million.
  • In the past 5 years, UroGen Pharma's Raw Materials ranged from a high of $2.4 million in Q1 2021 and a low of $893000.0 during Q2 2020